Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Robin P Kraak , Maik J Grundeken , Robbert J de Winter , et al Added: 3 years ago
In the past three decades, significant progress has been made in the treatment of coronary artery disease. From the introduction of balloon angioplasty by Andreas Grüntzig in 19771 to metallic drugeluting stents with thin stent struts coated with cytotoxic or cytostatic drugs,2,3 with biocompatible/biodegradable polymers,4 with or without endothelial progenitor cell-capturing technology.5 However… View more
Author(s): J Raider Estrada , Jonathan D Paul , Atman P Shah , et al Added: 3 years ago
While the breadth of procedural offerings in interventional cardiology (IC) has exponentially expanded over the past four decades to include cardiac structural, peripheral arterial, and venous interventions, percutaneous coronary intervention (PCI) remains at the core of the field, accounting for the greatest percentage of therapeutic catheter-based procedures performed by IC practitioners in the… View more
Author(s): Shao-Liang Chen , Imad Sheiban Added: 3 years ago
Bifurcation lesions account for approximately 20–30% of all percutaneous coronary interventions (PCIs). Coronary bifurcation sites are prone to developing obstructive atherosclerotic disease due to turbulent blood flow and change of shear stress. With the complexity of bifurcation lesions, several classification systems have been advocated in order to extablish percutaneous strategies.1–3 In fact… View more
Author(s): Giovanni Luigi De Maria , Adrian P Banning Added: 3 years ago
Detection of obstructive disease of the left main coronary artery (LMCA) is relatively unusual in the catheterisation laboratory, as it accounts for approximately 4 % of all coronary angiograms, with isolated LMCA disease observed in only 5–10 % of these cases.1 Intervention to the LMCA is, however, notable compared to the treatment of coronary stenosis elsewhere in the coronary tree. First,… View more
Author(s): Mehdi Shishehbor Added: 2 years ago
In this late-breaking interview from ACC.22, Dr Mehdi Shishehbor (University Hospitals Cleveland Medical Center, Cleveland, OH, US) discusses the outcomes of the Chocolate-Touch study, a multicentre prospective trial investigating the safety and effectiveness of the Chocolate Touch™ paclitaxel-coated balloon in superficial femoral or popliteal arteries compared to the commercially available… View more
Author(s): Stefan Bertog , Daniel Howard Steinberg , Nina Wunderlich , et al Added: 3 years ago
Left main coronary disease is a common problem faced by interventional cardiologists. Percutaneous left main intervention has gained popularity mainly as a result of recently published encouraging results of trials examining the use of drug-eluting stents. However, important questions remain unanswered in the interpretation, implications and treatment of left main stenosis. Nevertheless, use of… View more